Search
for
Sort by
Research 361–390 of 1000+
- Alopecia Areata in 12 years old female treated with Oral Azathioprine: A case report and review
- Hair Disorders
- Androgenic disorders of women: Diagnostic and therapeutic decision making
- Treatment of idiopathic facial hirsutism with medroxyprogesterone acetate iontophoresis
- Polycystic Ovary Syndrome
- Polycystic Ovary Syndrome, Insulin Resistance, and Obesity: Navigating the Pathophysiologic Labyrinth
- Adult polycystic ovary syndrome begins in childhood
- No Evidence that 2D:4D is Related to the Number of CAG Repeats in the Androgen Receptor Gene
- What may be the markers of the male equivalent of polycystic ovary syndrome?
- Chapter 17. Selective androgen receptor modulators (SARMs)
- Clinical use of 5α-reductase inhibitors
- Cyproterone Acetate: A Genotoxic Carcinogen?
- Polycystic Ovary Syndrome-Associated Acne: The Interplay of Hyperandrogenism, Insulin Resistance, and Therapeutic Strategies
- A review on follicular targeting for the treatment of hirsutism
- Management of teenagers with polycystic ovarian syndrome
- Neuroendocrine Controls of Keratin Expression in Human Skin
- Penis Endocrinology
- Subject Index
- Melatonin in the skin: synthesis, metabolism and functions
- Nonalcoholic fatty liver disease in young adult Egyptian women with polycystic ovary syndrome
- Ether: Fiction or Reality? A Review
- SUMMARIES OF PAPERS
- American Association of Clinical Endocrinologists, American College of Endocrinology, and Androgen Excess and PCOS Society Disease State Clinical Review: Guide to the Best Practices in the Evaluation and Treatment of Polycystic Ovary Syndrome - Part 1
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- Gender differences in skin: A review of the literature
- Dermatology of androgen-related disorders
- Prolactin: an emerging force along the cutaneous–endocrine axis
- Sulphation catalysed by the human cytosolic sulphotransferases - chemical defence or molecular terrorism?
- Idiopathic Hirsutism*
- Fluoroquinolone-induced serious, persistent, multisymptom adverse effects